These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29203268)

  • 1. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.
    Daneshmand S; Patel S; Lotan Y; Pohar K; Trabulsi E; Woods M; Downs T; Huang W; Jones J; O'Donnell M; Bivalacqua T; DeCastro J; Steinberg G; Kamat A; Resnick M; Konety B; Schoenberg M; Jones JS;
    J Urol; 2018 May; 199(5):1158-1165. PubMed ID: 29203268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
    Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
    J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing understaging of bladder cancer with the aid of photodynamic cystoscopy.
    Sfetsas K; Mitropoulos D
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):89-94. PubMed ID: 27053367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of Repeat Use of Blue Light Cystoscopy with Hexaminolevulinate for Patients with Urothelial Cell Carcinoma.
    Lane GI; Downs TM; Soubra A; Rao A; Hemsley L; Laylan C; Shi F; Konety B
    J Urol; 2017 Mar; 197(3 Pt 1):596-601. PubMed ID: 27664580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study.
    Smith AB; Daneshmand S; Patel S; Pohar K; Trabulsi E; Woods M; Downs T; Huang W; Taylor J; Jones J; O'Donnell M; Bivalacqua T; DeCastro J; Steinberg G; Kamat A; Resnick M; Konety B; Schoenberg M; Jones JS; Lotan Y;
    BJU Int; 2019 Jan; 123(1):35-41. PubMed ID: 29979488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
    Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
    J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of blue-light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.
    Lotan Y; Chaplin I; Ahmadi H; Meng X; Roberts S; Ladi-Seyedian S; Bagrodia A; Margulis V; Woldu S; Daneshmand S
    BJU Int; 2021 Jan; 127(1):108-113. PubMed ID: 32648957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
    Loidl W; Schmidbauer J; Susani M; Marberger M
    Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer.
    Clinton TN; Lotan Y
    Future Oncol; 2018 Nov; 14(27):2805-2810. PubMed ID: 29925279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study With Focus on Recurrence.
    Drejer D; Moltke AL; Nielsen AM; Lam GW; Jensen JB
    Urology; 2020 Mar; 137():91-96. PubMed ID: 31843623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic challenge of suspicious or positive malignant urine cytology findings when cystoscopy findings are normal: an outpatient blue-light flexible cystoscopy may solve the problem.
    Andersson M; Berger M; Zieger K; Malmström PU; Bläckberg M
    Scand J Urol; 2021 Aug; 55(4):263-267. PubMed ID: 34037496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.
    Yang LP
    Mol Diagn Ther; 2014 Feb; 18(1):105-16. PubMed ID: 24248555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden.
    Dansk V; Malmström PU; Bläckberg M; Malmenäs M
    Future Oncol; 2016; 12(8):1025-38. PubMed ID: 26975197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
    Stenzl A; Burger M; Fradet Y; Mynderse LA; Soloway MS; Witjes JA; Kriegmair M; Karl A; Shen Y; Grossman HB
    J Urol; 2010 Nov; 184(5):1907-13. PubMed ID: 20850152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
    Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
    Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.
    Rose JB; Armstrong S; Hermann GG; Kjellberg J; Malmström PU
    BJU Int; 2016 Jun; 117(6B):E102-13. PubMed ID: 26305667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
    Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
    Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.